The Challenge: Manual Product Release Workflows Created Delay and Deviation Risk
A global pharmaceutical leader faced inefficiencies in its product release process because key quality workflows still depended on site visits, paper records, and manual review. Those manual steps slowed release cycles, introduced Good Documentation Practice (GDP) errors, and made product-hold status difficult to see in real time.
Delays in change-control reviews extended hold times for site lots, sometimes by years. Human error, erroneous releases, and limited visibility into Product Hold data created direct operational cost and avoidable compliance risk.
- Paper-driven execution: site visits and paper records slowed completion, review, and analysis.
- Expensive deviations: deviations often cost $5,000 to $15,000 each, while CAPAs could range from $5,000 to $20,000 each.
- Limited release visibility: decision-makers lacked real-time data for Product Hold status and release metrics.
- Erroneous-release risk: manual handoffs increased the chance that high-risk quality events would be missed or delayed.
The Approach: ProcessX Workflows for Digital Quality and Product Hold Visibility
USDM implemented ProcessX as a GxP-ready digital quality platform, combining intelligent workflows, automated validation capabilities, and operational dashboards tailored to the customer's product-release process.
The implementation focused on controlled automation, data visibility, and inspection-ready evidence:
- Automating GMP workflow completion, review, and analysis.
- Implementing real-time dashboards for Product Hold and release metrics.
- Using AI-enabled trend analysis to identify potential risks and deviations earlier.
- Streamlining change-control processes with 21 CFR Part 11-compliant electronic signatures and audit trails.
- Enhancing traceability and visibility of holds across the enterprise.
By moving the release process into controlled digital workflows, the organization strengthened data integrity, reduced manual reconciliation, and gave Quality and Operations teams a shared source of truth for release decisions.
The Results: 67,200 Hours Saved and Lower Deviation Exposure
The digital quality process created measurable savings while reducing the risk of costly deviations and erroneous releases.
- 67,200 hours saved annually: the company eliminated 2,100 hours of manual work per year at each of 32 sites.
- High-cost deviations reduced: automation reduced exposure to deviations costing $5,000 to $15,000 each and CAPAs costing $5,000 to $20,000 each.
- Improved audit readiness: intelligent workflows, eSignatures, audit trails, and controlled records made quality evidence easier to defend.
- Faster release cycles: digital workflows decreased release cycle time and improved time-to-market for critical products.
- Real-time operational transparency: decision-makers gained live access to Product Hold data, improving response time and accountability.
USDM helped the organization move beyond digitization into true process optimization: automated quality workflows, actionable data, and compliant evidence operating together as a continuous compliance model.